Profil
Jeffrey G.
Hesselberg is currently the Vice President-Regulatory & Quality Affairs at Castle Creek Biosciences, Inc. He previously worked as the Director-Regulatory Affairs at ICOS Corp.
from 1996 to 2007 and as the Vice President-Regulatory Affairs at GTx, Inc. He holds an MBA degree from the University of Washington and an undergraduate degree from the University of Wisconsin.
Aktiva positioner av Jeffrey G. Hesselberg
| Företag | Position | Start |
|---|---|---|
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Generell Rådgivare | 2020-01-01 |
Tidigare kända positioner av Jeffrey G. Hesselberg
| Företag | Position | Slut |
|---|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Generell Rådgivare | 2007-04-01 |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Generell Rådgivare | - |
Jeffrey G. Hesselbergs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology Manufactures medications to treat inflammation and other serious diseases | Health Technology |
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of small molecules for the treatment of cancer | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Wisconsin
University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Develops gene therapies for patients with skin and genetic diseases | Health Technology |
















